Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab's Rapid Onset of Action in Prurigo Nodularis Patients | National Business

ZUG, Switzerland--(BUSINESS WIRE)--Oct 26, 2023--

Related Keywords

Switzerland ,United States ,Japan ,Taiwan ,Jessica Cohen ,Emil Ivanov ,Clin Pharmacol ,Christian Marcoux ,Acta Derm Venereol ,Corporate Communications ,Chugai Pharmaceutical Co Ltd ,Drug Administration ,New England Journal ,Breakthrough Therapy ,Injectable Aesthetics ,Dermatological Skincare ,Rev Clin ,Growth Factor ,Allergy Clin ,Investor Relations ,Business Wire ,National Business ,